Welcome to Valneva
A leading pure play vaccine company.
— June 08, 2017
Valneva Announces the Availability of Documentation for its Meetings of ShareholdersRead more
— April 18, 2017
Valneva Announces Signing of a New EB66® Commercial License with Bavarian Nordic
Valneva's CEO Thomas Lingelbach
comments on Group Strategy
— Product pipeline
Our goal is to develop and launch a continuous flow of products. We strive for a balance between in-house development and strategic partnerships to accelerate vaccine development.
– Upcoming conferences and fairs
Jefferies 2017 Global Healthcare Conference
New York, US
June 6-9, 2017
Kepler Biotech Days
June 8-9, 2017
2017 BIO International Convention
San Diego, US
June 19-22, 2017
16th Euro Global Summit and Expo on Vaccines & Vaccination; Accelerating Next Generation Vaccines for Global Health
June 19-21, 2017
A leading pure play vaccine company with international footprint.